Shanghai - Delayed Quote CNY

Sichuan Biokin Pharmaceutical Co.,Ltd. (688506.SS)

Compare
179.60
-13.10
(-6.80%)
At close: January 10 at 3:00:03 PM GMT+8
All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Cash Flows from Used in Operating Activities Direct
4,359,212.34
-615,351.11
-258,649.09
-135,031.19
78,457.85
Operating Cash Flow
--
-615,351.11
-258,649.09
-135,031.19
78,457.85
Investing Cash Flow
-728,797.98
-81,875.40
-34,546.14
156,147.46
-210,003.61
Financing Cash Flow
974,894.37
90,842.99
1,139,411.07
88,655.24
-64,759.19
End Cash Position
4,990,665.57
391,692.71
1,000,694.82
154,222.13
45,211.64
Capital Expenditure
-69,009.50
-81,939.19
-34,556.41
-44,603.26
-15,371.61
Issuance of Debt
1,458,930.00
447,700.00
375,000.00
242,000.00
150,000.00
Repayment of Debt
-368,689.50
-239,740.00
-161,000.00
-181,000.00
-194,734.20
Free Cash Flow
4,290,202.84
-697,290.30
-293,205.50
-179,634.45
63,086.24
12/31/2020 - 1/6/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers